(Q24200709)

1

0 references

Robert Andrew Moore

5

object named as

R Andrew Moore

0 references

Toni Tan

4

object named as

Toni Tan

0 references

author name string

Andrew S C Rice

2

0 references

Peter Cole

Cochrane Database of Systematic Reviews

3

0 references

publication date

28 February 2013

0 references

published in

0 references

cites work

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

The visual analogue pain intensity scale: what is moderate pain in millimetres?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Topical capsaicin (low concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Capsaicin 8% topical patch (Qutenza)--a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Reporting of adverse drug reactions in randomised controlled trials - a systematic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Systematic review of topical capsaicin for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Prevalence and comorbidity of chronic pain in the German general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

The Prevalence of Neuropathic Pain: Clinical Evaluation Compared with Screening Tools in a Community Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Topical capsaicin for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

Gabapentin for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

7 January 2021

Utility-based outcomes made easy: The number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

7 January 2021

Reporting of Adverse Effects in Clinical Trials Should Be Improved

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

7 January 2021

A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007393.PUB3

7 January 2021

10.1002/14651858.CD007393.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23450576

1 reference

Consolidated OpenCitations Corpus – April 2017